Bae-Jump V - Search Results

1

Discrete microfluidics for the isolation of circulating tumor cell subpopulations targeting fibroblast activation protein alpha and epithelial cell adhesion molecule.

Witek MA, Aufforth RD, Wang H, Kamande JW, Jackson JM, Pullagurla SR, Hupert ML, Usary J, Wysham WZ, Hilliard D, Montgomery S, Bae-Jump V, Carey LA, Gehrig PA, Milowsky MI, Perou CM, Soper JT, Whang YE, Yeh JJ, Martin G, Soper SA. Witek MA, et al. NPJ Precis Oncol. 2017;1:24. doi: 10.1038/s41698-017-0028-8. Epub 2017 Jul 25. NPJ Precis Oncol. 2017. PMID: 29657983 Free PMC article.

2

Association between uterine serous carcinoma and breast cancer.

Gehrig PA, Bae-Jump VL, Boggess JF, Groben PA, Fowler WC Jr, Van Le L. Gehrig PA, et al. Gynecol Oncol. 2004 Jul;94(1):208-11. doi: 10.1016/j.ygyno.2004.04.009. Gynecol Oncol. 2004. PMID: 15262144

3

Uterine serous and grade 3 endometrioid carcinomas: is there a survival difference?

Boruta DM 2nd, Gehrig PA, Groben PA, Bae-Jump V, Boggess JF, Fowler WC Jr, Van Le L. Boruta DM 2nd, et al. Cancer. 2004 Nov 15;101(10):2214-21. doi: 10.1002/cncr.20645. Cancer. 2004. PMID: 15452833 Free article.

4

Rapamycin inhibits hTERT telomerase mRNA expression, independent of cell cycle arrest.

Bae-Jump VL, Zhou C, Gehrig PA, Whang YE, Boggess JF. Bae-Jump VL, et al. Gynecol Oncol. 2006 Mar;100(3):487-94. doi: 10.1016/j.ygyno.2005.08.053. Epub 2005 Oct 24. Gynecol Oncol. 2006. PMID: 16249016

5

The PTEN tumor suppressor inhibits telomerase activity in endometrial cancer cells by decreasing hTERT mRNA levels.

Zhou C, Bae-Jump VL, Whang YE, Gehrig PA, Boggess JF. Zhou C, et al. Gynecol Oncol. 2006 May;101(2):305-10. doi: 10.1016/j.ygyno.2005.10.038. Epub 2005 Dec 27. Gynecol Oncol. 2006. PMID: 16380156

6

Estrogen-receptor-dependent regulation of telomerase activity in human endometrial cancer cell lines.

Boggess JF, Zhou C, Bae-Jump VL, Gehrig PA, Whang YE. Boggess JF, et al. Gynecol Oncol. 2006 Nov;103(2):417-24. doi: 10.1016/j.ygyno.2006.03.032. Epub 2006 May 11. Gynecol Oncol. 2006. PMID: 16690106

7

Induction of apoptosis and inhibition of telomerase activity by arsenic trioxide (As2O3) in endometrial carcinoma cells.

Zhou C, Boggess JF, Bae-Jump V, Gehrig PA. Zhou C, et al. Gynecol Oncol. 2007 Apr;105(1):218-22. doi: 10.1016/j.ygyno.2006.11.027. Epub 2007 Feb 2. Gynecol Oncol. 2007. PMID: 17275888

8

Outcomes in surgical stage I uterine papillary serous carcinoma.

Havrilesky LJ, Secord AA, Bae-Jump V, Ayeni T, Calingaert B, Clarke-Pearson DL, Berchuck A, Gehrig PA. Havrilesky LJ, et al. Gynecol Oncol. 2007 Jun;105(3):677-82. doi: 10.1016/j.ygyno.2007.01.041. Epub 2007 Mar 13. Gynecol Oncol. 2007. PMID: 17355889

9

The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.

Alvarez Secord A, Havrilesky LJ, Bae-Jump V, Chin J, Calingaert B, Bland A, Rutledge TL, Berchuck A, Clarke-Pearson DL, Gehrig PA. Alvarez Secord A, et al. Gynecol Oncol. 2007 Nov;107(2):285-91. doi: 10.1016/j.ygyno.2007.06.014. Epub 2007 Aug 6. Gynecol Oncol. 2007. PMID: 17688923

10

Arsenic trioxide (As2O3) inhibits expression of estrogen receptor-alpha through regulation of the mitogen-activated protein kinase (MAPK) pathway in endometrial cancer cells.

Bae-Jump VL, Zhou C, Boggess JF, Gehrig PA. Bae-Jump VL, et al. Reprod Sci. 2008 Dec;15(10):1011-7. doi: 10.1177/1933719108324134. Reprod Sci. 2008. PMID: 19088370

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

140 results

Search Page